These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 23289697)
1. Questions concerning the clinical translation of cell-based interventions under an innovation pathway. Sugarman J J Law Med Ethics; 2012; 40(4):945-50. PubMed ID: 23289697 [TBL] [Abstract][Full Text] [Related]
2. Translating stem cell research: challenges at the research frontier. Magnus D J Law Med Ethics; 2010; 38(2):267-76. PubMed ID: 20579250 [TBL] [Abstract][Full Text] [Related]
4. Reflections on governance models for the clinical translation of stem cells. Sugarman J J Law Med Ethics; 2010; 38(2):251-6. PubMed ID: 20579248 [TBL] [Abstract][Full Text] [Related]
5. Overseeing innovative therapy without mistaking it for research: a function-based model based on old truths, new capacities, and lessons from stem cells. Taylor PL J Law Med Ethics; 2010; 38(2):286-302. PubMed ID: 20579252 [TBL] [Abstract][Full Text] [Related]
7. Allowing innovative stem cell-based therapies outside of clinical trials: ethical and policy challenges. Hyun I J Law Med Ethics; 2010; 38(2):277-85. PubMed ID: 20579251 [TBL] [Abstract][Full Text] [Related]
8. Indian researchers accused of violating ethical guidelines. Mudur G BMJ; 2005 Jan; 330(7482):60. PubMed ID: 15637357 [No Abstract] [Full Text] [Related]
9. From bench to bedside and to health policies: ethics in translational research. Petrini C Clin Ter; 2011; 162(1):51-9. PubMed ID: 21448547 [TBL] [Abstract][Full Text] [Related]
11. Building an ethical foundation for first-in-human nanotrials. Dresser R J Law Med Ethics; 2012; 40(4):802-8. PubMed ID: 23289682 [TBL] [Abstract][Full Text] [Related]
12. Nanomedicine first-in-human research: challenges for informed consent. King NM J Law Med Ethics; 2012; 40(4):823-30. PubMed ID: 23289684 [TBL] [Abstract][Full Text] [Related]
13. Law, ethics, religion, and clinical translation in the 21st century. Trounson A Stem Cells; 2010 Jan; 28(1):2. PubMed ID: 19998372 [No Abstract] [Full Text] [Related]
15. Law, ethics, religion, and clinical translation in the 21st century--a discussion with John Sinden. Lako M; Trounson A; Daher S Stem Cells; 2010 Jan; 28(1):3-4. PubMed ID: 19998371 [No Abstract] [Full Text] [Related]
16. The Need for Beneficence and Prudence in Clinical Innovation with Autologous Stem Cells. Lipworth W; Stewart C; Kerridge I Perspect Biol Med; 2018; 61(1):90-105. PubMed ID: 29805150 [TBL] [Abstract][Full Text] [Related]
17. Translational networks in healthcare? Evidence on the design and initiation of organizational networks for knowledge mobilization. Fitzgerald L; Harvey G Soc Sci Med; 2015 Aug; 138():192-200. PubMed ID: 26117554 [TBL] [Abstract][Full Text] [Related]
18. Stem-cell-derived products: an FDA update. Moos M Trends Pharmacol Sci; 2008 Dec; 29(12):591-3. PubMed ID: 18937983 [TBL] [Abstract][Full Text] [Related]
19. Clinical translation of stem cell therapies: a bridgeable gap. Cuende N; Izeta A Cell Stem Cell; 2010 Jun; 6(6):508-12. PubMed ID: 20569686 [TBL] [Abstract][Full Text] [Related]
20. Law, ethics, religion, and clinical translation in the 21st century--a discussion with Derek Hei. Interview by Majlinda Lako, Alan O. Trounson, Susan Rainey Daher. Hei D Stem Cells; 2010 Mar; 28(3):387-9. PubMed ID: 20166151 [No Abstract] [Full Text] [Related] [Next] [New Search]